Soc. Generale Call 65 NDAQ 21.06..../ DE000SV44G39 /
| 2024-06-06 1:19:21 PM | Chg.-0.004 | Bid2:19:38 PM | Ask2:19:38 PM | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 0.007EUR | -36.36% | 0.006 Bid Size: 10,000 |
0.020 Ask Size: 10,000 |
Nasdaq Inc | 65.00 USD | 2024-06-21 | Call |
GlobeNewswire
2:03 PM
OceanPal Inc. Reports Financial Results for the First Quarter Ended March 31, 2024
GlobeNewswire
2:00 PM
Fulcrum Therapeutics to Participate in the Goldman Sachs’ 45th Annual Global Healthcare Conference
GlobeNewswire
2:00 PM
Intersection of Art and Football: Brera Ilch, of the Brera Holdings Family of Soccer Clubs, Partners...
GlobeNewswire
2:00 PM
electroCore, Inc. Announces Closing of $9.3 Million Registered Direct Offering and Concurrent Privat...
GlobeNewswire
2:00 PM
New Documentary Produced By Joaquin Phoenix Now Available Exclusively on Gaia, “Love Over Money”
GlobeNewswire
2:00 PM
American Oncology Network Expands Radiation Oncology Services, Opens New Clinic
GlobeNewswire
2:00 PM
Madrigal Pharmaceuticals Announces New Data from the Phase 3 MAESTRO-NASH Study of Rezdiffra™ (resme...
GlobeNewswire
2:00 PM
Tonix Pharmaceuticals Announces Two Oral Presentations and One Poster Presentation Involving TNX-150...
GlobeNewswire
2:00 PM
Helio Genomics to Host In-Person & Virtual KOL Event in New York to Review Results from CLiMB Pivota...
GlobeNewswire
2:00 PM
ASP Isotopes Inc. Announces Closing of an Additional Offering of Convertible Notes by Quantum Leap E...
GlobeNewswire
2:00 PM
Pliant Therapeutics Presents Data from its Bexotegrast Program at the European Association for the S...
GlobeNewswire
2:00 PM
CERo Therapeutics, Inc. Successfully Completes IND-Enabling Toxicology Studies for Lead Compound CER...
GlobeNewswire
1:57 PM
Ocuphire Pharma Announces Presentations on the Development of APX3330 for Diabetic Retinopathy at Re...
GlobeNewswire
1:40 PM
OneMedNet Significantly Expands Industry Access to Proprietary iRWD™ Network and Platform by Joining...
